![Lois Chandler](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Lois Chandler
Verksamhetschef på
Taxus Cardium Pharmaceuticals Group, Inc.
Profil
Lois A. Chandler is currently the Chief Operating Officer at Taxus Cardium Pharmaceuticals Group, Inc. She previously worked as the Vice President-Product Development at Activation Therapeutics, Inc. from 2006 to 2019.
Dr. Chandler completed her undergraduate degree at Stanford University and holds a doctorate from the University of Southern California.
Aktiva positioner av Lois Chandler
| Företag | Position | Start |
|---|---|---|
Taxus Cardium Pharmaceuticals Group, Inc.
 Taxus Cardium Pharmaceuticals Group, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops and commercializes angiogenic gene therapy products for cardiovascular disease | Verksamhetschef | 2019-07-01 |
Tidigare kända positioner av Lois Chandler
| Företag | Position | Slut |
|---|---|---|
Activation Therapeutics, Inc.
 Activation Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Develops late-stage clinical and commercial development of regenerative medicine therapeutics | Företagsledare/Principal | 2019-01-01 |
Lois Chandlers utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
14
Första gradens relationer
4
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 4 |
|---|---|
Stanford University
 Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Southern California
 University of Southern California Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Taxus Cardium Pharmaceuticals Group, Inc.
Taxus Cardium Pharmaceuticals Group, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops and commercializes angiogenic gene therapy products for cardiovascular disease | Health Technology |
Activation Therapeutics, Inc.
Activation Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Develops late-stage clinical and commercial development of regenerative medicine therapeutics | Health Technology |
